Prevalence and Risk Factors of Dermatologic Diseases among People with HIV

Strategic Insights -

A new longitudinal cohort study published in the Journal of the American Academy of Dermatology has investigated the prevalence, incidence, and risk factors of dermatologic diseases among people with human immunodeficiency virus (HIV). The study, conducted in Washington, D.C., analyzed data from 11,738 adults enrolled in the DC Cohort between 2011 and 2023. The results showed that 49.4% of participants had at least one dermatologic diagnosis, with infectious conditions being the most common. Incidence declined from 2011 to 2024 across all categories, with a significant reduction in infectious, inflammatory, and malignant cases. The study identified demographic, immune, structural, and behavioral factors as major risk drivers among people with HIV, emphasizing the need for targeted care.

Key Takeaways:

  • The study included 11,738 adults enrolled in the DC Cohort between 2011 and 2023.
  • 49.4% of participants had at least one dermatologic diagnosis, with infectious conditions being the most common (41.4%).
  • Incidence declined from 2011 to 2024 across all categories: infectious (463 to 41), inflammatory (306 to 62), and malignant (31 to 6) cases per 1000.
  • Demographic, immune, structural, and behavioral factors drive risk among people with HIV.
  • Targeted care is needed to address the unique needs of people with HIV.
  • The study highlights the importance of regular dermatologic check-ups for people with HIV.
  • The prevalence of dermatologic diseases among people with HIV is a significant public health concern.
  • The study's findings can inform policy and clinical practice to improve the health outcomes of people with HIV.

Statistics:

  • 11,738 adults were enrolled in the DC Cohort between 2011 and 2023.
  • 49.4% of participants had at least one dermatologic diagnosis.
  • Infectious conditions were the most common (41.4%).
  • Incidence declined from 2011 to 2024: infectious (463 to 41), inflammatory (306 to 62), and malignant (31 to 6) cases per 1000.

Sources:

  • Prevalence, incidence, and risk factors for dermatologic conditions in people with HIV in the modern antiretroviral era: A cohort study in Washington, DC. Journal of the American Academy of Dermatology, 2025.
  • Mosby-elsevier, 360 Park Avenue South, New York, NY 10010-1710, USA (Elsevier - www.elsevier.com; Journal of the American Academy of Dermatology - www.journals.elsevier.com/journal-of-the-american-academy-of-dermatology/)
  • George Washington University, Milken Institute School of Public Health, Washington, District of Columbia.